Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone

Background and study aims: Endoscopic resection is one treatment option for residual or locally recurrent esophageal cancer after definitive chemoradiotherapy or radiotherapy alone. However, little is known about the clinical benefit of salvage endoscopic resection for these lesions. Therefore, the...

Full description

Bibliographic Details
Main Authors: Shinya Kondo, Masahiro Tajika, Tsutomu Tanaka, Takeshi Kodaira, Nobumasa Mizuno, Kazuo Hara, Susumu Hijioka, Hiroshi Imaoka, Hidemi Goto, Kenji Yamao, Yasumasa Niwa
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2016-08-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-109609
id doaj-d2aaa0195a4b409694bd5a01a106de3a
record_format Article
spelling doaj-d2aaa0195a4b409694bd5a01a106de3a2020-11-25T03:41:45ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362016-08-010408E841E84810.1055/s-0042-109609Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy aloneShinya Kondo0Masahiro Tajika1Tsutomu Tanaka2Takeshi Kodaira3Nobumasa Mizuno4Kazuo Hara5Susumu Hijioka6Hiroshi Imaoka7Hidemi Goto8Kenji Yamao9Yasumasa Niwa10Department of Gastroenterology, Aichi Cancer Center Aichi Hospital, Aichi, JapanDepartment of Endoscopy, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Endoscopy, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, JapanDepartment of Gastroenterology, Aichi Cancer Center Hospital, Aichi, JapanDepartment of Endoscopy, Aichi Cancer Center Hospital, Aichi, JapanBackground and study aims: Endoscopic resection is one treatment option for residual or locally recurrent esophageal cancer after definitive chemoradiotherapy or radiotherapy alone. However, little is known about the clinical benefit of salvage endoscopic resection for these lesions. Therefore, the effectiveness and prognostic factors of salvage endoscopic resection were investigated. Patients and methods: A total of 37 patients with esophageal squamous cell carcinoma (SCC) who underwent salvage endoscopic resection after definitive chemoradiotherapy or radiotherapy alone were reviewed. The method of salvage endoscopic resection was endoscopic mucosal resection using a cap (EMR-C), strip biopsy, or endoscopic submucosal dissection. The effectiveness and prognostic factors of salvage endoscopic resection were retrospectively analyzed. Results: A total of 37 patients with 49 lesions underwent salvage endoscopic resection. Baseline clinical stages were I in 23 patients, II in 3 patients, III in 9 patients, and IV in 2 patients. The number of locoregional recurrences and residual lesions were 35 and 14, respectively. The curative en bloc resection rate was 53.1 % (26/49). The total incidence of complications was 18.9 % (7/37); all were successfully managed conservatively. The 3-year and 5-year overall survival rates were 72.9 % and 53.3 %, respectively, with a median follow-up period of 54 months. Baseline clinical T1 – 2 and N0 were significant factors for good prognosis in terms of overall survival on univariate analysis. Conclusions: Salvage endoscopic resection, especially EMR-C, is a safe and feasible procedure to control residual or recurrent superficial esophageal SCC after definitive chemoradiotherapy or radiotherapy alone. The present results showed that baseline clinical T1 – 2 and N0 before chemoradiotherapy or radiotherapy were significant prognostic factors.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-109609
collection DOAJ
language English
format Article
sources DOAJ
author Shinya Kondo
Masahiro Tajika
Tsutomu Tanaka
Takeshi Kodaira
Nobumasa Mizuno
Kazuo Hara
Susumu Hijioka
Hiroshi Imaoka
Hidemi Goto
Kenji Yamao
Yasumasa Niwa
spellingShingle Shinya Kondo
Masahiro Tajika
Tsutomu Tanaka
Takeshi Kodaira
Nobumasa Mizuno
Kazuo Hara
Susumu Hijioka
Hiroshi Imaoka
Hidemi Goto
Kenji Yamao
Yasumasa Niwa
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
Endoscopy International Open
author_facet Shinya Kondo
Masahiro Tajika
Tsutomu Tanaka
Takeshi Kodaira
Nobumasa Mizuno
Kazuo Hara
Susumu Hijioka
Hiroshi Imaoka
Hidemi Goto
Kenji Yamao
Yasumasa Niwa
author_sort Shinya Kondo
title Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
title_short Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
title_full Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
title_fullStr Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
title_full_unstemmed Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
title_sort prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
publisher Georg Thieme Verlag KG
series Endoscopy International Open
issn 2364-3722
2196-9736
publishDate 2016-08-01
description Background and study aims: Endoscopic resection is one treatment option for residual or locally recurrent esophageal cancer after definitive chemoradiotherapy or radiotherapy alone. However, little is known about the clinical benefit of salvage endoscopic resection for these lesions. Therefore, the effectiveness and prognostic factors of salvage endoscopic resection were investigated. Patients and methods: A total of 37 patients with esophageal squamous cell carcinoma (SCC) who underwent salvage endoscopic resection after definitive chemoradiotherapy or radiotherapy alone were reviewed. The method of salvage endoscopic resection was endoscopic mucosal resection using a cap (EMR-C), strip biopsy, or endoscopic submucosal dissection. The effectiveness and prognostic factors of salvage endoscopic resection were retrospectively analyzed. Results: A total of 37 patients with 49 lesions underwent salvage endoscopic resection. Baseline clinical stages were I in 23 patients, II in 3 patients, III in 9 patients, and IV in 2 patients. The number of locoregional recurrences and residual lesions were 35 and 14, respectively. The curative en bloc resection rate was 53.1 % (26/49). The total incidence of complications was 18.9 % (7/37); all were successfully managed conservatively. The 3-year and 5-year overall survival rates were 72.9 % and 53.3 %, respectively, with a median follow-up period of 54 months. Baseline clinical T1 – 2 and N0 were significant factors for good prognosis in terms of overall survival on univariate analysis. Conclusions: Salvage endoscopic resection, especially EMR-C, is a safe and feasible procedure to control residual or recurrent superficial esophageal SCC after definitive chemoradiotherapy or radiotherapy alone. The present results showed that baseline clinical T1 – 2 and N0 before chemoradiotherapy or radiotherapy were significant prognostic factors.
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-109609
work_keys_str_mv AT shinyakondo prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT masahirotajika prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT tsutomutanaka prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT takeshikodaira prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT nobumasamizuno prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT kazuohara prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT susumuhijioka prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT hiroshiimaoka prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT hidemigoto prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT kenjiyamao prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
AT yasumasaniwa prognosticfactorsforsalvageendoscopicresectionforesophagealsquamouscellcarcinomaafterchemoradiotherapyorradiotherapyalone
_version_ 1724528583866580992